XT
AQST icon

XTX Topco’s Aquestive Therapeutics AQST Stock Holding History

XTX Topco’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.2K Sell
11,829
-66,512
-85% -$280K ﹤0.01% 3725
2026
Q1 		$325K Buy
+78,341
New +$318K 0.01% 2419
2025
Q4 		– Sell
-60,776
Closed -$340K – 3299
2025
Q3 		$340K Buy
60,776
+46,142
+315% +$200K 0.02% 1411
2025
Q2 		$48.4K Sell
14,634
-63,888
-81% -$183K ﹤0.01% 2019
2025
Q1 		$228K Buy
+78,522
New +$238K 0.01% 1608
2024
Q2 		– Sell
-11,618
Closed -$49.5K – 1841
2024
Q1 		$49.5K Buy
+11,618
New +$38.7K 0.01% 1476
2023
Q4 		– Sell
-52,980
Closed -$81.1K – 1566
2023
Q3 		$81.1K Sell
52,980
-85,165
-62% -$146K 0.01% 1212
2023
Q2 		$228K Buy
+138,145
New +$250K 0.04% 922
2021
Q2 		– Sell
-10,970
Closed -$57K – 791
2021
Q1 		$57K Buy
+10,970
New +$58.4K 0.03% 613

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

XTX Topco's AQST Position: Q2 2026 in Review

XTX Topco reduced its Aquestive Therapeutics (AQST) stake by 85% in Q2 2026, selling an estimated $280K and leaving 11,829 shares worth $49.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3725.

XTX Topco first reported a position in AQST in Q1 2021 and has held it in 9 quarters since. The position peaked at $340K in Q3 2025. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • XTX Topco held 11,829 shares of Aquestive Therapeutics worth $49.2K as of Q2 2026.
  • XTX Topco sold 66,512 Aquestive Therapeutics shares in Q2 2026, an estimated $280K.
  • Aquestive Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3725 holding.
  • XTX Topco first reported a position in Aquestive Therapeutics in Q1 2021 and has held it in 9 quarters since.
  • XTX Topco's Aquestive Therapeutics position peaked at $340K in Q3 2025.
  • 184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.